These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
31. Cross reactivity between fibrinogen and epsilon heavy chain antiserum in immunofixation electrophoresis. Tai HL; Lam CW; Lam CW; Ng CK; Cheung RC Pathology; 2005 Oct; 37(5):384-5. PubMed ID: 16194851 [No Abstract] [Full Text] [Related]
32. [Rare forms of myeloma disease]. Egorov IV Klin Med (Mosk); 2004; 82(2):50-5. PubMed ID: 15106513 [TBL] [Abstract][Full Text] [Related]
33. [Heavy chain disease. Report of four cases]. Silva-Moreno M; Ruiz-Arguelles GJ; Lopez-Karpovitch X; Labardini-Mendez J Sangre (Barc); 1983; 28(1):89-98. PubMed ID: 6408748 [No Abstract] [Full Text] [Related]
34. ["Heavy chain disease". A preliminary study of 2 cases]. Lindholm L; Westin J; Weinfeld A; Eyrich R Nord Med; 1970 Dec; 84(49):1573. PubMed ID: 5488585 [No Abstract] [Full Text] [Related]
35. [Heavy chain syndromes. A brief review and report of a case of IgG heavy chain disease]. Vadstrup S Ugeskr Laeger; 1973 Jun; 135(25):1330-2. PubMed ID: 4757125 [No Abstract] [Full Text] [Related]
36. Arthropathy in multiple myeloma. Dawson AA Ann Phys Med; 1966 Feb; 8(5):185-6. PubMed ID: 5909822 [No Abstract] [Full Text] [Related]
37. Thyroid gland involvement with multiple myeloma. A new case-report. Mugnier B; Mattei JP; Arniaud D; Denizot A; Roux H Rev Rhum Engl Ed; 1998; 65(7-9):512-3. PubMed ID: 9785401 [No Abstract] [Full Text] [Related]
38. A comparison of several immunochemical approaches for the screening of alpha chain disease. Orr KB Diagn Immunol; 1983; 1(1):43-8. PubMed ID: 6437724 [TBL] [Abstract][Full Text] [Related]